Hillstream BioPharma to Present at the Virtual Sidoti Micro-Cap Conference on January 18-19, 2023
BRIDGEWATER, N.J., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream” or the “Company”), a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers, will present at the Virtual Sidoti Micro-Cap Conference being held on January 18-19, 2023.
Mr. Randy Milby, Founder and Chief Executive Officer of Hillstream BioPharma, is scheduled to present on Thursday, January 19, 2023 at 10:00 a.m. EST and will also be available for 1-on-1 meetings with the investment community.
To register for the conference, access the livestream, and request to participate in 1-on-1 meetings with Mr. Milby, please access this link: https://sidoti.zoom.us/webinar/register/WN_AGPD5ts5STqZfzhlcoUVrQ
To view the archived recordings for the presentation, please visit the Hillstream BioPharma website at: ir.hillstreambio.com.
About Hillstream BioPharma, Inc.
Investor Relations Contact:
Town Hall: What Do MSPs Need the Most Help With
Conference Boxed Lunches - For Diamond, Platinum, Super Pass, Exhibitor/Conference, Speaker, Press Pass Holders